Tackling the (un)affordability of medicines for cardiometabolic risk factors worldwide: a call to action

Summary box Cardiovascular diseases are a leading cause of death globally, with low- and middle-income countries (LMICs) facing the highest burden due to limited access to affordable treatment, health system constraints and socioeconomic challenges.